|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
7
|
|
gptkbp:bfsParent
|
gptkb:Lansoprazole_Delayed-Release_Capsules
|
|
gptkbp:administrative_division
|
take before meals
|
|
gptkbp:body_style
|
round
|
|
gptkbp:brand
|
gptkb:Prevacid_Solu_Tab
|
|
gptkbp:category
|
Category B
|
|
gptkbp:clinical_trial
|
various clinical trials
long-term use may lead to vitamin B12 deficiency
may affect absorption of other medications
may increase risk of Clostridium difficile infection
|
|
gptkbp:color
|
pink
|
|
gptkbp:contraindication
|
hypersensitivity to Lansoprazole
|
|
gptkbp:dosage_form
|
orally disintegrating tablet
|
|
gptkbp:duration
|
24 hours
|
|
gptkbp:effective_date
|
FDA approved
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:flavor
|
gptkb:plant
|
|
gptkbp:form
|
gptkb:tablet
|
|
gptkbp:has_ability
|
15 mg
30 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lansoprazole Orally Disintegrating Tablets
|
|
gptkbp:indication
|
gptkb:Zollinger-Ellison_syndrome
ulcer treatment
|
|
gptkbp:ingredients
|
gptkb:Lansoprazole
C16 H14 F3 N3 O2 S
|
|
gptkbp:interacts_with
|
gptkb:methotrexate
gptkb:clopidogrel
gptkb:warfarin
|
|
gptkbp:is_atype_of
|
A02 B C03
|
|
gptkbp:is_used_for
|
treating gastroesophageal reflux disease (GERD)
|
|
gptkbp:lifespan
|
1.5 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
various manufacturers
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:population
|
gptkb:Person
adults
|
|
gptkbp:premiered_on
|
1-3 hours
|
|
gptkbp:safety_features
|
consult a doctor before use
|
|
gptkbp:side_effect
|
headache
nausea
abdominal pain
diarrhea
constipation
|
|
gptkbp:storage
|
store at room temperature
|
|
gptkbp:symptoms
|
confusion
blurred vision
none reported
severe dizziness
|